Providing the latest, cutting-edge advances in diabetes research, prevention, and care, the American Diabetes Association (ADA) program is categorized into themes allowing attendees to focus on specific interests including: Clinical Diabetes/Therapeutics, and Insulin Action/Molecular Metabolism. ADA typically releases titles from the final program 4 weeks before conference start, but abstracts are not released until 2 days prior to conference start due to ADA’s embargo policy.